Estimated savings are ₹3,357.49 crore (as on November 4, 2026), with 70 companies reporting revised MRPs for 120 drugs.

A statement by post author, said on 2026-11-06. Statements are as reported by the cited publishers — not verified by DecisionGateway.

₹3,357.49 crore (as on November 4, 2026), with 70 companies reporting revised MRPs for 120 drugs